iPSC Signature Series

Since induced pluripotent stem cells (iPSCs) were first developed, in 2006, they have represented an area of immense potential in disease modeling, drug discovery, and therapeutics. In recent years, advances in biology and technology have accelerated their entry into the clinical arena, and leading researchers globally are now progressing iPSC products across a wide range of indications. Despite these recent advances, significant manufacturing and regulatory hurdles stand between promising iPSC research and their entry into the market as viable solutions for patients.

The 2025 iPSC Scientific Signature Series Event will bring together global key opinion leaders from academic research labs and clinical centers, regulatory agencies, and industry. These experts will discuss and deliberate on solutions that need to be found for the barriers that are impeding iPSC therapies’ clinical translation.

Join us for front-row access to pivotal discussions, where experts will collaboratively address the most pressing challenges in the field to advance the translation of iPSC therapeutics. 

DATE

Saturday, May 10, 2025

AGENDA (PRELIMINARY)

  • Check-In and Coffee: 07:30–08:00
  • Morning Sessions: 08:00-11:45
  • Lunch: 11:45-12:15
  • Afternoon Sessions: 12:15-16:00
  • Scientific Signature Series Cocktail Reception: 16:00-17:30

Separate Registration Required

 OVERARCHING GOAL 

This event aims to build consensus on the optimal approaches to iPSC product characterization with regards to patient safety.

 PLANNING FACULTY 

 PROGRAM 

Program details will be coming soon

 THANK YOU TO OUR 2024 SPONSORS 

Interested in Becoming an ISCT 2025 Scientific Signature Series Sponsor?

Sponsorship Opportunities:

  • Title Sponsorship
  • Thought Leadership Package
  • Lunch and Coffee Sponsorship
  • Reception Sponsorship
  • Brand Visibility Package

REGISTRATION DETAILS

To participate, you must register in the New Orleans Annual Meeting and pay an additional USD $35 registration fee to this event. 

Limited number of audience seats available for ISCT 2025 delegates.

For more information, please contact Sam Baker at sam@isctglobal.org.

iPSC CULTURE AND APPLICATION IN CELL AND GENE THERAPY

If you are interested in learning everything you need to know about the fundamentals of iPSCs, register for ISCT Workforce Development’s newest course designed by experts from the ISCT-JSRM iPSC Committee. This live-virtual self-paced course covers:

  • Reprogramming Somatic Cells to iPSCs
  • Quality by Design (QbD) in Culturing iPSCs for Cell Therapy
  • Development of Multi-Engineered, iPSC-Derived Therapeutic Products